Adverum Biotechnologies (FRA:AVU0) Current Deferred Taxes Liabilities : €0.00 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Adverum Biotechnologies Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Adverum Biotechnologies's current deferred tax liabilities for the quarter that ended in Mar. 2025 was €0.00 Mil.

Adverum Biotechnologies Current Deferred Taxes Liabilities Historical Data

The historical data trend for Adverum Biotechnologies's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adverum Biotechnologies Current Deferred Taxes Liabilities Chart

Adverum Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Adverum Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Adverum Biotechnologies Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Adverum Biotechnologies's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adverum Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adverum Biotechnologies Inc (FRA:AVU0) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

ADVM:USA 0HA3:UK

Address

100 Cardinal Way, Redwood CIty, CA, USA, 94063

Website

https://www.adverum.com

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Adverum Biotechnologies Headlines

No Headlines